Suppr超能文献

非肝硬化性肝外门静脉血栓形成患者食管胃静脉曲张出血的内镜治疗:一项长期随访研究

Endoscopic treatment of esophagogastric variceal bleeding in patients with noncirrhotic extrahepatic portal vein thrombosis: a long-term follow-up study.

作者信息

Spaander Manon C W, Darwish Murad Sarwa, van Buuren Henk R, Hansen Bettina E, Kuipers Ernst J, Janssen Harry L A

机构信息

Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.

出版信息

Gastrointest Endosc. 2008 May;67(6):821-7. doi: 10.1016/j.gie.2007.08.023. Epub 2008 Jan 18.

Abstract

BACKGROUND

Esophagogastric variceal bleeding is the most important complication of extrahepatic portal vein thrombosis (EPVT) and is usually treated endoscopically. Little is known about the prognosis of these patients.

OBJECTIVES

To investigate the long-term clinical outcome and efficacy of endoscopic treatment in patients with esophagogastric variceal bleeding secondary to EPVT.

DESIGN

Retrospective observational study.

SETTINGS

Single university center.

PATIENTS

Twenty-seven consecutive patients with esophagogastric variceal bleeding, secondary to noncirrhotic, nonmalignant EPVT, who underwent endoscopic treatment between 1982 and 2005.

INTERVENTIONS

Endoscopic band ligation and/or endoscopic sclerotherapy.

MAIN OUTCOME MEASUREMENTS

The overall rebleeding risk, overall survival, complications of the endoscopic procedures, and predictive values of rebleeding. Analyses were performed by the Kaplan-Meier method and univariate Cox regression.

RESULTS

All patients were followed-up after the first endoscopically treated variceal bleeding. A total of 241 endoscopic procedures were performed. In all patients, initial control of bleeding was obtained. The overall rebleeding risk was 23% (95% CI, 0%-24%) at 1 year and 37% (95% CI, 43%-83%) at 5 years. Extension of thrombosis into the splenic vein and the presence of fundal varices were significant predictors of rebleeding, with a nearly 5-fold increased risk for patients with EPVT and fundal varices at the time of the first variceal hemorrhage (hazard ratio 5.07, P = .01). A portosystemic shunt procedure was performed in 5 patients: 4 for variceal bleeding and in one patient for refractory ascites. Seven patients died, none from variceal bleeding. Overall 5-year and 10-year survivals were 100% and 62% (95% CI, 38%-96%), respectively.

LIMITATIONS

Retrospective design.

CONCLUSIONS

In patients with variceal bleeding secondary to EPVT endoscopic treatment, in particular, band ligation appears safe and effective. EPVT-related mortality is primarily determined by other causes than variceal bleeding.

摘要

背景

食管胃静脉曲张出血是肝外门静脉血栓形成(EPVT)最重要的并发症,通常采用内镜治疗。对这些患者的预后了解甚少。

目的

探讨内镜治疗继发于EPVT的食管胃静脉曲张出血患者的长期临床结局和疗效。

设计

回顾性观察研究。

地点

单一大学中心。

患者

1982年至2005年间连续27例因非肝硬化、非恶性EPVT继发食管胃静脉曲张出血并接受内镜治疗的患者。

干预措施

内镜下套扎术和/或内镜硬化治疗。

主要观察指标

总体再出血风险、总生存率、内镜操作并发症及再出血的预测值。采用Kaplan-Meier法和单因素Cox回归分析。

结果

所有患者在首次内镜治疗静脉曲张出血后均进行了随访。共进行了241次内镜操作。所有患者出血均得到初步控制。1年时总体再出血风险为23%(95%CI,0%-24%),5年时为37%(95%CI,43%-83%)。血栓扩展至脾静脉和存在胃底静脉曲张是再出血的重要预测因素,首次静脉曲张出血时合并EPVT和胃底静脉曲张的患者再出血风险增加近5倍(风险比5.07,P = 0.01)。5例患者接受了门体分流手术:4例因静脉曲张出血,1例因难治性腹水。7例患者死亡,均非死于静脉曲张出血。总体5年和10年生存率分别为100%和62%(95%CI,38%-96%)。

局限性

回顾性设计。

结论

对于继发于EPVT的静脉曲张出血患者,内镜治疗尤其是套扎术似乎安全有效。EPVT相关的死亡率主要由静脉曲张出血以外的其他原因决定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验